Home » Topics » BioWorld Science

BioWorld Science
RSS

Cathepsin inhibitors from Ono particularly useful for inhibiting bone resorption

Oct. 23, 2001

Phase II trials of new treatment for atrial fibrillation set to begin

Oct. 23, 2001

New agents for pain and inflammation designed at AstraZeneca

Oct. 23, 2001

Sangamo achieves first milestone in ZFP therapeutics program

Oct. 23, 2001

CPMP lifts Serdolect suspension; Lundbeck moves forward with postmarketing studies

Oct. 23, 2001

Significant beneficial effects reported for PARP inhibitor in animal model of myocardial infarction

Oct. 23, 2001

PARS inhibitors such as PJ-34 may be suitable for the therapy of septic shock

Oct. 23, 2001

Cell Genesys commences phase II trial of GVAX vaccine for pancreatic cancer

Oct. 23, 2001

Vivus updates product pipeline

Oct. 23, 2001

Biogen highlights Q3 developments

Oct. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...